EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Implications of Ki‐67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions

Masatoshi Murakami, Nao Fujimori iD, Kazuhide Matsumoto, Keijiro Ueda, Kohei Nakata iD, Masafumi Nakamura, Takeo Yamamoto, Yoshinao Oda iD, Tetsuhide Ito, Yoshihiro Ogawa

Journal of Hepato-Biliary-Pancreatic Sciences · 2026

DOI: 10.1002/jhbp.70028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Hepato-Biliary-Pancreatic Sciences, 2026. Verfasst von Masatoshi Murakami und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Ki-67 Antigen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pancreatic neuroendocrine tumors (PanNETs) show heterogeneity, including temporal shifts in proliferation and hormone production; however, their clinical implications remain uncertain.

Methods

This retrospective study included 114 patients with metastatic or recurrent PanNETs at Kyushu University Hospital. Paired specimens from 46 patients (27 synchronous metastases and 19 recurrences) were evaluated for Ki‐67 index and tumor grade. Proliferation change was defined as grade progression or a ≥ 10% absolute Ki‐67 increase. Hormonal phenotype changes were assessed in all patients.

Results

In metastases, mean Ki‐67 increased from 12.3% to 16.4% ( p = 0.0043); 22.2% showed a ≥ 10% increase, and 33.3% progressed in grade. In recurrences, Ki‐67 increased from 8.8% to 9.3% ( p = 0.8256); 15.8% showed a ≥ 10% increase, and 21.1% progressed in grade. Median progression‐free survival was 7.8 months in metastases and 17.1 months in recurrences. Median overall survival was significantly longer in the recurrence group (124.8 vs. 32.5 months, p = 0.003). Hormonal transformation occurred in six patients (5.3%), mostly during progressive hepatic disease.

Conclusion

A subset of PanNETs exhibited increased proliferation of metastases or recurrence without detrimental survival effects, possibly because of timely treatment adjustments. Rebiopsy may be useful for detecting proliferative changes, whereas hormonal shifts highlight tumor heterogeneity and warrant continued clinical and biochemical monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeuroendocrine TumorsKi-67 AntigenHumansMaleFemaleRetrospective StudiesMiddle AgedAgedAdultNeoplasm GradingNeoplasm Recurrence, LocalAged, 80 and over

Stichwörter der Autor:innen

grade changehormonal phenotypemetastasis and recurrencepancreatic neuroendocrine tumorstumor heterogeneity

Substanzen

Ki-67 Antigen

Autor:innen und Institutionen

  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Neuroendocrine Tumor Centre, Fukuoka Sanno Hospital, Fukuoka, Japan.
  • Department of Gastroenterology, Graduate School of Medical Sciences, International University of Health and Welfare, Fukuoka, Japan.

ORCID-Profile: Nao Fujimori, Kohei Nakata, Yoshinao Oda

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Murakami, M., Fujimori, N., Matsumoto, K., Ueda, K., Nakata, K., Nakamura, M., Yamamoto, T., Oda, Y., Ito, T., & Ogawa, Y. (2026). Clinical Implications of Ki‐67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions. Journal of Hepato-Biliary-Pancreatic Sciences. https://doi.org/10.1002/jhbp.70028

Vancouver

Murakami M, Fujimori N, Matsumoto K, Ueda K, Nakata K, Nakamura M, et al. Clinical Implications of Ki‐67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions. Journal of Hepato-Biliary-Pancreatic Sciences. 2026. doi:10.1002/jhbp.70028

BibTeX
@article{Murakami2026,
  author = {Murakami, Masatoshi and Fujimori, Nao and Matsumoto, Kazuhide and Ueda, Keijiro and Nakata, Kohei and Nakamura, Masafumi and Yamamoto, Takeo and Oda, Yoshinao and Ito, Tetsuhide and Ogawa, Yoshihiro},
  title = {Clinical Implications of Ki‐67 Index, Grade and Hormonal Changes in Pancreatic Neuroendocrine Tumors: Insights Into Tumor Heterogeneity Based on Primary and Secondary Lesions},
  journal = {Journal of Hepato-Biliary-Pancreatic Sciences},
  year = {2026},
  doi = {10.1002/jhbp.70028}
}
Kostenlos starten →